These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24049782)

  • 1. Patients have undetectable HIV after coming off treatment.
    Hayward P
    Lancet Infect Dis; 2013 Aug; 13(8):660-1. PubMed ID: 24049782
    [No Abstract]   [Full Text] [Related]  

  • 2. Performance of an ultrasensitive assay to test undetectable viral load specimens using the branched DNA assay.
    de Mendoza C; Holguin A; Soriano V
    AIDS; 1998 Sep; 12(13):1727-9. PubMed ID: 9764800
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral load testing.
    Sax P; Flory J
    AIDS Clin Care; 1996 Apr; 8(4):31-2. PubMed ID: 11363258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors. The French ALT Study Group.
    Candotti D; Calvez V; Autran B; Costagliola D; Rouzioux C; Agut H
    J Acquir Immune Defic Syndr; 1999 Jul; 21(3):253-5. PubMed ID: 10421251
    [No Abstract]   [Full Text] [Related]  

  • 5. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.
    Popper SJ; Sarr AD; Guèye-Ndiaye A; Mboup S; Essex ME; Kanki PJ
    J Virol; 2000 Feb; 74(3):1554-7. PubMed ID: 10627569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey.
    Lambert-Niclot S; Tubiana R; Beaudoux C; Lefebvre G; Caby F; Bonmarchand M; Naouri M; Schubert B; Dommergues M; Calvez V; Flandre P; Poirot C; Marcelin AG
    AIDS; 2012 May; 26(8):971-5. PubMed ID: 22382146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring viral load in the clinical setting.
    Harrigan R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S34-40. PubMed ID: 8595506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of HIV-1 viral load for drug resistance surveillance using dried blood spots: literature review and modeling of contribution of DNA and RNA.
    Parkin NT
    AIDS Rev; 2014; 16(3):160-71. PubMed ID: 25221990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
    Visseaux B; Charpentier C; Taieb A; Damond F; Bénard A; Larrouy L; Chêne G; Brun-Vézinet F; Matheron S; Descamps D;
    AIDS; 2013 Jan; 27(2):292-5. PubMed ID: 23095312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients.
    Burgard M; Boufassa F; Viard JP; Garrigue I; Ruffault A; Izopet J; Vabret A; Descamps D; Colson P; Seigneurin JM; Rouzioux C;
    AIDS; 2009 Oct; 23(16):2165-71. PubMed ID: 19657270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral load and response to treatment of HIV.
    Ioannidis JP; Cappelleri JC; Lau J
    N Engl J Med; 1996 Jun; 334(25):1671; author reply 1672-3. PubMed ID: 8628372
    [No Abstract]   [Full Text] [Related]  

  • 13. The additional use of viral entry inhibitors during autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma and HIV-1 infection.
    Hütter G; Allers K; Schneider T
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):586-7. PubMed ID: 19892025
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients.
    Zida S; Tuaillon E; Barro M; Kwimatouo Lekpa Franchard A; Kagoné T; Nacro B; Ouedraogo AS; Bolloré K; Sanosyan A; Plantier JC; Meda N; Sangaré L; Rouzioux C; Rouet F; Kania D
    J Clin Microbiol; 2016 Jun; 54(6):1641-1643. PubMed ID: 27008874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undetectable plasma HIV-1 RNA with strong gag-pol specific interferon-gamma ELISPOT response in an HIV-1 clade A/E-infected child untreated with antiretroviral therapy.
    Ananworanich J; Pancharoen C; Sirivichayakul S; Buranapraditkun S; Apateerapong W; Ubolyam S; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2004; 22(2-3):165-9. PubMed ID: 15565954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.
    Aldámiz-Echevarría T; González-García J; Von Wichmann MA; Crespo M; López-Aldeguer J; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Bellón JM; Montes M; Berenguer J
    Ann Hepatol; 2015; 14(4):464-9. PubMed ID: 26019032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volunteers needed for study of HIV viral load test.
    Oncology (Williston Park); 1996 Apr; 10(4):449-50. PubMed ID: 8723276
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.
    Yukl SA; Boritz E; Busch M; Bentsen C; Chun TW; Douek D; Eisele E; Haase A; Ho YC; Hütter G; Justement JS; Keating S; Lee TH; Li P; Murray D; Palmer S; Pilcher C; Pillai S; Price RW; Rothenberger M; Schacker T; Siliciano J; Siliciano R; Sinclair E; Strain M; Wong J; Richman D; Deeks SG
    PLoS Pathog; 2013; 9(5):e1003347. PubMed ID: 23671416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
    Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
    Braun DL; Rauch A; Aouri M; Durisch N; Eberhard N; Anagnostopoulos A; Ledergerber B; Müllhaupt B; Metzner KJ; Decosterd L; Böni J; Weber R; Fehr J;
    PLoS One; 2015; 10(7):e0133028. PubMed ID: 26176696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.